A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation

Clinical trial NCT06990711 · RECRUITING

Trial details

NCT number: NCT06990711
Sponsor: Washington University School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Antibody Mediated Rejection of Lung Transplant

Start date: 2025-11-06
Primary completion: 2027-12-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.